MENU
+Compare
MGNX
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$1.78
Change
+$0.07 (+4.09%)
Capitalization
95.9M

MGNX MacroGenics Forecast, Technical & Fundamental Analysis

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MGNX with price predictions
Apr 23, 2025

MGNX in +22.66% Uptrend, rising for three consecutive days on April 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MGNX advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MGNX's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on MGNX as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MGNX just turned positive on April 10, 2025. Looking at past instances where MGNX's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MGNX broke above its upper Bollinger Band on April 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MGNX entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.826) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.642) is also within normal values, averaging (252.992).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MGNX is expected to report earnings to rise 171.67% to -65 cents per share on May 13

MacroGenics MGNX Stock Earnings Reports
Q1'25
Est.
$-0.65
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.69
Q2'24
Missed
by $0.23
Q1'24
Missed
by $0.20
The last earnings report on March 20 showed earnings per share of -23 cents, beating the estimate of -40 cents. With 468.30K shares outstanding, the current market capitalization sits at 95.90M.
A.I. Advisor
published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JSDA0.210.01
+5.00%
Jones Soda Co.
OPHLY4.150.09
+2.22%
Ono Pharmaceutical Co., Ltd.
SCGLY9.520.18
+1.93%
Societe Generale
ENLAY8.46-0.06
-0.70%
ENEL Societa per Azioni
BRCHF0.17N/A
-2.78%
Brainchip Holdings Ltd.

MGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with AMRN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+12.17%
AMRN - MGNX
44%
Loosely correlated
-1.24%
IOVA - MGNX
40%
Loosely correlated
-0.62%
ATOS - MGNX
38%
Loosely correlated
+11.25%
ORMP - MGNX
34%
Loosely correlated
+0.66%
ARWR - MGNX
33%
Loosely correlated
+5.26%
More